Elevance Health (ELV) Projected to Announce Quarterly Earnings on Wednesday

Elevance Health (NYSE:ELV) is expected to announce its Q3 2026 results before the market opens on Wednesday, October 21st. Analysts expect the company to announce earnings of $4.70 per share and revenue of $49.29 billion for the quarter. Individuals are encouraged to explore the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Wednesday, October 21, 2026 at 8:30 AM ET.

Elevance Health Trading Down 0.0%

Elevance Health stock opened at $428.11 on Monday. The firm has a 50-day moving average of $404.18 and a 200-day moving average of $386.62. Elevance Health has a one year low of $274.84 and a one year high of $436.24. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.52 and a quick ratio of 1.52. The company has a market cap of $92.84 billion, a price-to-earnings ratio of 19.03, a P/E/G ratio of 2.23 and a beta of 0.70.

Wall Street Analysts Forecast Growth

ELV has been the topic of a number of recent research reports. The Goldman Sachs Group reaffirmed a “neutral” rating and issued a $395.00 target price on shares of Elevance Health in a research report on Thursday, July 16th. Weiss Ratings restated a “hold (c)” rating on shares of Elevance Health in a research note on Thursday, August 13th. Truist Financial raised their price target on Elevance Health from $450.00 to $475.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. TD Cowen boosted their price target on Elevance Health from $400.00 to $465.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. Finally, Barclays boosted their price target on Elevance Health from $457.00 to $469.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 7th. Fifteen investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $441.71.

Elevance Health Company Profile

Elevance Health, Inc (NYSE: ELV) is a diversified health benefits company that provides health insurance and related services in the United States. Its offerings serve employers, individuals and families, as well as members of government-sponsored programs, including Medicare and Medicaid. The company provides medical, pharmacy, behavioral health and other benefits through a range of health plans and specialty products.

Elevance Health operates its health benefits businesses through a portfolio that includes Blue Cross and Blue Shield-affiliated plans and other insurance offerings.